Frontiers reaches 6.4 on Journal Impact Factors
Precision treatments comprise pharmacological inhibitors that target a specific genetic defect or a particular pathway, but may also include therapies targeting a specific cell population, such as immunotherapies. All of these approaches exploit defined vulnerabilities of a particular disease to maximize the therapeutic window.
The mission of this section is to provide a platform for novel approaches, which optimize the precision of diagnosis and treatment that will ultimately allow us to tailor treatments for each individual patient.
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ, Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Precision Medicine welcomes submissions of the following article types: Case Report, Clinical Study Protocol, Clinical Trial, Editorial, Erratum, Focused Review, Frontiers Commentary, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Precision Medicine, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Precision Medicine will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine.